RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 70 filers reported holding RA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $14,894,000 | -37.7% | 310,218 | -39.1% | 0.01% | -21.4% |
| Q4 2019 | $23,888,000 | +30.4% | 509,009 | -34.3% | 0.01% | +27.3% |
| Q3 2019 | $18,320,000 | +1442.1% | 774,645 | +1861.1% | 0.01% | +1000.0% |
| Q2 2019 | $1,188,000 | +99.3% | 39,500 | +48.5% | 0.00% | – |
| Q1 2019 | $596,000 | +29.6% | 26,600 | +5.1% | 0.00% | – |
| Q4 2018 | $460,000 | +46.0% | 25,300 | +45.4% | 0.00% | – |
| Q3 2018 | $315,000 | +115.8% | 17,400 | +18.4% | 0.00% | – |
| Q2 2018 | $146,000 | -25.1% | 14,700 | +41.3% | 0.00% | – |
| Q2 2017 | $195,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 5,493,636 | $54,662,000 | 2.56% |
| RA Capital Management | 3,851,808 | $38,325,000 | 2.49% |
| VHCP Management II, LLC | 544,612 | $5,419,000 | 1.62% |
| Novo Holdings A/S | 1,465,838 | $14,585,000 | 1.47% |
| Consonance Capital Management LP | 1,454,761 | $14,475,000 | 0.93% |
| Rock Springs Capital Management LP | 750,000 | $7,463,000 | 0.29% |
| Eventide Asset Management | 388,000 | $3,861,000 | 0.16% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 382,700 | $3,808,000 | 0.13% |
| Tekla Capital Management LLC | 219,952 | $2,189,000 | 0.08% |
| FIRST MANHATTAN CO. LLC. | 777,487 | $7,735,000 | 0.04% |